» Articles » PMID: 20039063

Effects of Measured Susceptibility Genes on Cancer Risk in Family Studies

Overview
Journal Hum Genet
Specialty Genetics
Date 2009 Dec 30
PMID 20039063
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Numerous family studies have been performed to assess the associations between cancer incidence and genetic and non-genetic risk factors and to quantitatively evaluate the cancer risk attributable to these factors. However, mathematical models that account for a measured hereditary susceptibility gene have not been fully explored in family studies. In this report, we proposed statistical approaches to precisely model a measured susceptibility gene fitted to family data and simultaneously determine the combined effects of individual risk factors and their interactions. Our approaches are structured for age-specific risk models based on Cox proportional hazards regression methods. They are useful for analyses of families and extended pedigrees in which measured risk genotypes are segregated within the family and are robust even when the genotypes are available only in some members of a family. We exemplified these methods by analyzing six extended pedigrees ascertained through soft-tissue sarcoma patients with p53 germ-line mutations. Our analyses showed that germ-line p53 mutations and sex had significant interaction effects on cancer risk. Our proposed methods in family studies are accurate and robust for assessing age-specific cancer risk attributable to a measured hereditary susceptibility gene, providing valuable inferences for genetic counseling and clinical management.

Citing Articles

Spatially varying effects of measured confounding variables on disease risk.

Wu C, Chu Y, Shete S, Chen C Int J Health Geogr. 2021; 20(1):45.

PMID: 34763707 PMC: 8582111. DOI: 10.1186/s12942-021-00298-6.


Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter Cohorts.

Shin S, Dodd-Eaton E, Peng G, Bojadzieva J, Chen J, Amos C Cancer Res. 2019; 80(2):354-360.

PMID: 31719101 PMC: 6980689. DOI: 10.1158/0008-5472.CAN-19-0728.


Bayesian Semiparametric Estimation of Cancer-specific Age-at-onset Penetrance with Application to Li-Fraumeni Syndrome.

Shin S, Yuan Y, Strong L, Bojadzieva J, Wang W J Am Stat Assoc. 2019; 114(526):541-552.

PMID: 31485091 PMC: 6724737. DOI: 10.1080/01621459.2018.1482749.


Bayesian estimation of a semiparametric recurrent event model with applications to the penetrance estimation of multiple primary cancers in Li-Fraumeni syndrome.

Shin S, Li J, Ning J, Bojadzieva J, Strong L, Wang W Biostatistics. 2018; 21(3):467-482.

PMID: 30445420 PMC: 7307969. DOI: 10.1093/biostatistics/kxy066.


Estimating Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPRO.

Peng G, Bojadzieva J, Ballinger M, Li J, Blackford A, Mai P Cancer Epidemiol Biomarkers Prev. 2017; 26(6):837-844.

PMID: 28137790 PMC: 5457344. DOI: 10.1158/1055-9965.EPI-16-0695.


References
1.
Malkin D, Li F, Strong L, Fraumeni Jr J, Nelson C, Kim D . Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990; 250(4985):1233-8. DOI: 10.1126/science.1978757. View

2.
Greenberg D . Inferring mode of inheritance by comparison of lod scores. Am J Med Genet. 1989; 34(4):480-6. DOI: 10.1002/ajmg.1320340406. View

3.
Law J, Strong L, Chidambaram A, Ferrell R . A germ line mutation in exon 5 of the p53 gene in an extended cancer family. Cancer Res. 1991; 51(23 Pt 1):6385-7. View

4.
Breslow N, Day N . Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ. 1987; (82):1-406. View

5.
Strong L, Williams W, Tainsky M . The Li-Fraumeni syndrome: from clinical epidemiology to molecular genetics. Am J Epidemiol. 1992; 135(2):190-9. DOI: 10.1093/oxfordjournals.aje.a116271. View